Geriatric Medicine News

Cognitive behavioral therapy for insomnia may help prevent major depression among older adults with insomnia disorder, according to results of a randomized clinical trial published in JAMA Psychiatry.

Brigham and Women’s Hospital will soon commence a clinical trial to test the first nasally administered treatment intended to arrest the progression of Alzheimer’s disease, according to a press release.

The American Academy of Neurology has issued ethical guidance on Aduhelm that outlines important points for neurologists to communicate to patients eligible for the treatment.

In 2019, more than 67 million adults in the U.S. reported having a disability, a 1% increase since the prevalence was last examined in 2016, according to findings published in JAMA Network Open.

The Alzheimer's Association and collaborators announced the formation of a national database, the National Treatment and Diagnostic Alzheimer’s Registry, at the Clinical Trials on Alzheimer’s Disease conference.

Additional contingency reserves related to uncertainty surrounding the potential use of Aduhelm by individuals with Medicare contributed to projected increases in the 2022 Medicare Part B premium and deductible, according to CMS.

Patients with alopecia areata had increased risk for dementia, according to a nationwide cohort study published in Journal of Clinical Psychiatry.

Diets with higher inflammatory potential appeared linked to increased risk for incident dementia, according to results of a population-based study published in Neurology.

Estimating treatment effects on caregivers can help determine the cost-effectiveness of treatments for Alzheimer’s disease, according to results of an economic evaluation published in JAMA Network Open.

Increasing calcium and protein intake through dairy products reduced the risk for falls and fractures among older adults living in care homes by 33%, according to results of a randomized controlled trial published in the BMJ.